Global Iloprost Market, By Drug Class (Polycyclic aromatic hydrocarbon (PAH), Prostacyclin Analogs, Others), Demographic (Adult, Geriatric), Application (Pulmonary Arterial Hypertension, Systemic Sclerosis, Others), Dosage Form (Solution, Other), Route of Administration (Intravenous, Inhalation), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Industry Trends and Forecast to 2030.
Iloprost Market Analysis and Size
Iloprost is a drug that is used to treat pulmonary arterial hypertension (PAH). In patients with PAH, iloprost may help them exercise more and reduce the progression of their symptoms. Iloprost belongs to the class of drugs known as vasodilators. It acts by relaxing blood vessels throughout the body, including the lungs. It is a prostacyclin PGI2 analog that dilates the vascular beds of the systemic and pulmonary arteries. This medication is available as a solution to be inhaled through the mouth. During the day, it is commonly inhaled six to nine times. It is available under the brand name ventavis. Side effects of this drug include flushing, blurred vision, cough, headache, nausea, vomiting, tightening of jaw muscles, wheezing and breathing difficulties, among others.
Data Bridge Market Research analyses that the Global Iloprost Market which was USD 106.17 million in 2022, would rocket up to USD 212.23 million by 2030, and is expected to undergo a CAGR of 11.50% during the forecast period 2023-2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Drug Class (Polycyclic aromatic hydrocarbon (PAH), Prostacyclin Analogs, Others), Demographic (Adult, Geriatric), Application (Pulmonary Arterial Hypertension, Systemic Sclerosis, Others), Dosage Form (Solution, Other), Route of Administration (Intravenous, Inhalation), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)
|
|
Countries Covered
|
U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E., Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa
|
|
Market Players Covered
|
Bayer AG (Germany), Vectura Group plc (U.K.), VisionGate, Inc. (U.S.), Janssen Global Services, LLC (U.S.), Transo-Pharm Handels-GmbH (Germany), LGM Pharma (U.S.), Newchem (India), and YONSUNG Fine Chemicals Co., Ltd. (South Korea)
|
|
Market Opportunities
|
|
Market Definition
Iloprost, in the industry of pharmaceuticals, is a drug belonging to the anticonvulsant class of medications. It was initially developed to treat epileptic seizures, specifically partial seizures. Over time, its use has expanded to include the management of neuropathic pain and certain types of chronic pain. Iloprost functions by affecting the nerves and chemicals in the body that are involved in causing seizures and various types of pain.
Global Iloprost Market Dynamics
Drivers
- Growing Prevalence of Neuropathic Pain Disorders
The rising incidence of neuropathic pain disorders globally is a significant driver for the iloprost market. Neuropathic pain, often associated with conditions like diabetic neuropathy, post-herpetic neuralgia, and trigeminal neuralgia, necessitates effective pain management. Iloprost has proven efficacy in managing neuropathic pain, driving its demand and adoption.
- Expanding Applications and Off-Label Usage
Iloprost's versatility in treating various medical conditions beyond its initial intended use, such as anxiety disorders, migraines, and restless legs syndrome, contributes to market growth. Physicians and healthcare practitioners increasingly prescribe iloprost off-label for these conditions, broadening its market reach and fueling demand.
Opportunity
- Rising Awareness and Education Initiatives
There is a substantial opportunity for market growth through increased awareness and educational initiatives regarding iloprost's benefits, optimal usage, and potential side effects. Educating healthcare professionals, patients, and caregivers about the appropriate use of iloprost, its efficacy in managing various conditions, and safety precautions can enhance its acceptance and adoption. This educational approach can not only expand the market but also foster responsible usage, which is crucial in ensuring positive outcomes and mitigating potential risks.
Restraints/Challenges
- Concerns Regarding Abuse and Dependency
One significant restraint for the iloprost market is the rising concern regarding its potential for abuse and dependency. Reports of misuse and addiction, particularly when combined with other substances like opioids, have raised regulatory scrutiny and led to tighter control and monitoring of iloprost prescriptions. This has the potential to limit its usage and impact the overall market growth.
This iloprost market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the iloprost market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Impact and Current Market Scenario of Raw Material Shortage and Shipping Delays
Data Bridge Market Research offers a high-level analysis of the market and delivers information by keeping in account the impact and current market environment of raw material shortage and shipping delays. This translates into assessing strategic possibilities, creating effective action plans, and assisting businesses in making important decisions.
Apart from the standard report, we also offer in-depth analysis of the procurement level from forecasted shipping delays, distributor mapping by region, commodity analysis, production analysis, price mapping trends, sourcing, category performance analysis, supply chain risk management solutions, advanced benchmarking, and other services for procurement and strategic support.
Recent Development
- In September 2023, Pfizer Inc. and BioNTech SE announced that they received approval from the U.S. Food and Drug Administration (FDA) for their supplemental Biologics License Application (COMIRNATY 2023-2024 Formulation). This approval covers individuals aged 12 and above, and it includes emergency use authorization for children aged 6 months to 11 years, specifically for their Omicron XBB.1.5-adapted monovalent COVID-19 vaccine. The current vaccine season's recommendation is for a single dose for most individuals aged 5 and older. However, children under 5 years old may qualify for additional doses of this season's vaccine if they have not already completed a three-dose series with earlier formulations of a COVID-19 vaccine
Global Iloprost Market Scope
The global iloprost market is segmented on the basis of product type, application, route of administration, mode of purchase, and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
- Capsule
- Tablet
Application
- Epilepsy
- Neuropathic Pain
- Restless Legs Syndrome
Route of Administration
- Oral
- Parenteral
- Intravenous
Mode of Purchase
- Prescription
- Retail
- Over the Counter
Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
Global Iloprost Market Regional Analysis/Insights
The iloprost market is analyzed and market size insights and trends are provided by country, product type, application, route of administration, mode of purchase, and distribution channel as referenced above.
The countries covered in the global iloprost market report are U.S., Canada, Mexico, Brazil, Argentina, Peru, rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, rest of Middle East and Africa.
North America is expected to dominate and register the highest growth rate in the iloprost market due to rise in the surge in the approvals of products for the treatment and rise in the initiatives taken by the government and pharmaceutical organizations to spread awareness regarding the disease in this region.
Asia-Pacific is the expected region in terms of growth in iloprost market due to rise in the prevalence of acute lymphocytic/lymphoblastic leukemia (ALL) in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the Market scenario for individual countries. Also, the presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Iloprost Market Share Analysis
The iloprost market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to iloprost market.
Some of the major players operating in the iloprost market are:
- Bayer AG (Germany)
- Vectura Group plc (U.K.)
- VisionGate, Inc. (U.S.)
- Janssen Global Services, LLC (U.S.)
- Transo-Pharm Handels-GmbH (Germany)
- LGM Pharma (U.S.)
- Newchem (India)
- YONSUNG Fine Chemicals Co., Ltd. (South Korea)
SKU-